ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/18/2025
Back to search
Official data from USPTO
ELI-CEL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
12/20/2025
Trademark type
Word
Nice classes
5
Filing date
02/12/2021
Registration date
07/26/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/26/2022
Last transaction
12/20/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
US
Examiner
TULLY, MATTHEW
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Genetix Biotherapeutics, Inc.
bluebird bio, Inc.
bluebird bio, Inc.
Bluebird Bio (UK) Ltd.
Representatives
Christopher K. Albert Hamilton, Brook, Smith & Reynolds, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of genetic diseasesadrenoleukodystrophy and adrenomyeloneuropathy
Publications
History of USPTO decisions and trademark events.
35 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/14/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/18/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/18/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/18/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/13/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/23/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/12/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/02/2022
FIMP
FINAL DISPOSITION PROCESSED
11/01/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/26/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/26/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/26/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
07/26/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/10/2022
PUBO
PUBLISHED FOR OPPOSITION
05/10/2022
GPNX
NOTIFICATION PROCESSED BY IB
05/09/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/20/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/20/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/20/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/02/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/01/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/31/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/31/2022
RFNT
REFUSAL PROCESSED BY IB
10/30/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/09/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/04/2021
RFRR
REFUSAL PROCESSED BY MPU
10/04/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/21/2021
CNRT
NON-FINAL ACTION WRITTEN
09/20/2021
DOCK
ASSIGNED TO EXAMINER
09/09/2021
CHLD
CHANGE OF OWNER RECEIVED FROM IB
08/13/2021
MAFR
APPLICATION FILING RECEIPT MAILED
04/27/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/23/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/22/2021
Continuous trademark protection
Get notified about every new filing that threatens ELI-CEL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.